back to top
HomeSTOCKSFantastic Result; Share Jumped 7%; Target ₹1642; FII Holds 26%, DII Holds...

Fantastic Result; Share Jumped 7%; Target ₹1642; FII Holds 26%, DII Holds 25%

Hot Stocks Alert Join

Cipla Ltd (NSE: CIPLA) Stock Market News: The net profit of the drug maker Cipla Ltd increased by 32.25 percent to 1,068.41 crore during the October-December month of the current fiscal year. 

Following the release of the quarterly results, Cipla shares saw an increase today. The rise in the range of 7.30 percent was observed in the shares today.

The shares of the company started trading for Rs 1395.95 according to the BSE. After a while, it crossed the value of Rs 1412.55. This is the 52-week high of the company.

Cipla Limited said in an announcement on the stock exchange on Monday that it had reported a consolidated profit of the equivalent of 807.83 crore during the same time frame one year ago.

Operating income rose to 13.66 percent to 6,603.81 crore during the review quarter from 5,810.09 crore in the same time frame the previous year. 

The company also reported that the total cost of operations increased by 8.78 percent to 5,119.81 crore during the December quarter up from 4,706.47 crore in the period between October and December of the previous financial year.

Cipla’s overall earnings for the third quarter grew by 14.58 percent to 6788.44 crore. 

In the period its earnings from the pharmaceutical industry were at 6,365.06 crore, with the remainder coming from new ventures was 280.51 crore.

Shares Jumped By 35% In The Last 6 Months

Over the past 6 months shares of the company have increased by 35 percent.

The 52-week low of the company is around 852. Cipla’s market cap is around Rs 1,13,527 Cr. Brokerage has set a target of Rs 1642 for this share.

About Cipla Ltd

Cipla Limited is an India-based firm. It manufactures drugs, and medical chemicals along with botanical and herbal products. It has two segments which are Pharmaceuticals and New Ventures. 

The Pharmaceutical segment is responsible for developing, manufacturing, and selling generic or branded generic medications and Active Pharmaceutical Ingredients (API). 

The New Ventures segment runs the company, as well as consumer health, biosimilars, and specialty businesses. 

The company’s products cover advanced generics, antibiotics drugs, anti-retroviral, respiratory, urology, as well as the Central Nervous System (CNS). 

The business’s location for marketing is in India and also South Africa, the United States, South Africa and The Rest of the World. 

The total operating revenue earned is 15790.60 crores. Equity capital of 161.43 crores.

Fundamental Analysis of Cipla Ltd

Market Cap₹ 1,13,527 Cr.
Current Price₹ 1,403.50
52-wk High₹ 1,425
52-wk Low₹ 852
Stock P/E32.88
Book Value₹ 307
Dividend0.60 %
ROCE18.0 %
ROE12.8 %
Face Value₹ 2.00
P/B Value4.64
OPM24.3 %
EPS₹ 45.9
Debt₹ 961 Cr.
Debt to Equity0.04

Cipla Ltd Share Price Target 2024 To 2030

Year1st Target2nd Target
2024₹1530₹1642
2025₹1650₹1745
2026₹1859₹2000
2027₹2100₹2170
2028₹2248₹2415
2029₹2645₹2745
2030₹2890₹3000
Hot Stocks Alert Join

Cipla Ltd Shareholding Pattern

Promoters Holding
Dec 202233.61%
Mar 202333.55%
June 202333.46%
Sept 202333.46%
Dec 202333.46%
FII Holding
Dec 202228.39%
Mar 202327.42%
June 202325.49%
Sept 202325.74%
Dec 202325.73%
DII Holding
Dec 202220.87%
Mar 202321.83%
June 202324.05%
Sept 202323.90%
Dec 202324.05%
Hot Stocks Alert Join
Govt. Holding
Dec 20220.21%
Mar 20230.21%
June 20230.21%
Sept 20230.21%
Dec 20230.21%
Public Holding
Dec 202216.91%
Mar 202316.99%
June 202316.76%
Sept 202316.68%
Dec 202316.53%

Cipla Ltd Share: Last 5 Years’ Financial Condition

To gain a better understanding of how the market is performing, let’s look at the outlook of this share in the previous years. 

However, investors should be aware of the risks and the market conditions before making any investment decision.

Last 5 Years’ Sales:

2019₹ 16,362 Cr
2020₹ 17,132 Cr
2021₹ 19,160 Cr
2022₹ 21,763 Cr
2023₹ 25,350 Cr
Hot Stocks Alert Join

Last 5 Years’ Net Profit:

2019₹ 1,492 Cr
2020₹ 1,500 Cr
2021₹ 2,389 Cr
2022₹ 2,547 Cr
2023₹ 3,743 Cr

Last 5 Years’ Debt-To-Equity Ratio:

20190.29
20200.18
20210.08
20220.04
20230.02

Last 10 Years’ Profit Growth:

10 Years:6%
5 Years:16%
3 Years:26%
Current Year:48%

Last 10 years’ Return on Equity (ROE):

10 Years:11%
5 Years:12%
3 Years:13%
Last Year:13%

Sales Growth Over 10 Years:

10 Years:11%
5 Years:8%
3 Years:10%
Current Year:14%

Conclusion

This article is a complete guide about Cipla Ltd Share.

These information and forecasts are based on our analysis, research, company fundamentals and history, experiences, and various technical analyses. 

Also, We have talked in detail about the share’s future prospects and growth potential.

Hopefully, these informations will help you in your further investment. 

If you are new to our website and want to get all the latest updates related to the stock market, join us on Telegram Group.

If you have any further queries, please comment below. We will be happy to answer all your questions. 

If you like this information, share the article with as many people as possible.

Also Read: ₹110 Share Got Project From NHAI; President Holding 55%; Governor Holding 26%

Disclaimer: Dear readers, we’d like to inform you that we are not authorized by SEBI (Securities and Exchange Board of India). The information on this site is only for informational and educational purposes and shouldn’t be considered financial advice or stock recommendations. Also, the share price predictions are completely for reference purposes. The price predictions will only be valid when there are positive signs on the market. Any uncertainty about the company’s future or the current state of the market will not be considered in this study. We are not responsible for any financial loss you might incur through the information on this site. We are here to provide timely updates about the stock market and financial products to help you make better investment choices. Do your own research before any investment.

BEST FOR YOU

LEAVE A REPLY

Please enter your comment!
Please enter your name here